# Symrise AG – FDA Inspection, Mar 9, 2018

Source: https://www.keypedia.com/records/fda_inspections/symrise-ag/dff38aca-8cc2-4e18-8148-c6d0c0017d98
Source feed: FDA_Inspections

> FDA inspection 1046108 of Symrise AG, March 09, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1046108
- Company Name: Symrise AG
- Inspection Date: 2018-03-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1289898 - 2023-12-05
- FDA Inspection 1135051 - 2020-07-07
- [FDA Inspection 968502 - 2016-04-22](https://www.keypedia.com/records/fda_inspections/symrise-ag/46ebe67b-971a-42dd-97e0-ef56244936e2)
- FDA Inspection 818239 - 2013-02-05

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/symrise-ag/98cd9c8d-0b68-42ac-a5d1-33ae318aeb6d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c